VCP/p97 inhibitor (Cleave Therapeutics)

N/A

Report date: 2025/01/26 15:40:37
NME

Base Information

Drug NameVCP/p97 inhibitor (Cleave Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransitional endoplasmic reticulum ATPase inhibitors
TargetsTransitional endoplasmic reticulum ATPase
Therapy Area/IndicationsNerve DegenerationHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCleave Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCleave Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A